Your browser doesn't support javascript.
loading
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel.
Jiménez, Natalia; Reig, Òscar; Marín-Aguilera, Mercedes; Aversa, Caterina; Ferrer-Mileo, Laura; Font, Albert; Rodriguez-Vida, Alejo; Climent, Miguel Ángel; Cros, Sara; Chirivella, Isabel; Domenech, Montserrat; Figols, Mariona; González-Billalabeitia, Enrique; Jiménez Peralta, Daniel; Rodríguez-Carunchio, Leonardo; García-Esteve, Samuel; Garcia de Herreros, Marta; Ribal, Maria J; Prat, Aleix; Mellado, Begoña.
Affiliation
  • Jiménez N; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Reig Ò; Fundació Clínic per a la Recerca Biomèdica, 08036 Barcelona, Spain.
  • Marín-Aguilera M; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Aversa C; Fundació Clínic per a la Recerca Biomèdica, 08036 Barcelona, Spain.
  • Ferrer-Mileo L; Medical Oncology Department, Hospital Clínic, 08036 Barcelona, Spain.
  • Font A; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain.
  • Rodriguez-Vida A; Department of Medicine, University of Barcelona, 08036 Barcelona, Spain.
  • Climent MÁ; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Cros S; Fundació Clínic per a la Recerca Biomèdica, 08036 Barcelona, Spain.
  • Chirivella I; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Domenech M; Fundació Clínic per a la Recerca Biomèdica, 08036 Barcelona, Spain.
  • Figols M; Medical Oncology Department, Hospital Clínic, 08036 Barcelona, Spain.
  • González-Billalabeitia E; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain.
  • Jiménez Peralta D; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Rodríguez-Carunchio L; Fundació Clínic per a la Recerca Biomèdica, 08036 Barcelona, Spain.
  • García-Esteve S; Medical Oncology Department, Hospital Clínic, 08036 Barcelona, Spain.
  • Garcia de Herreros M; Uro-Oncology Unit, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain.
  • Ribal MJ; Medical Oncology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, 08916 Badalona, Spain.
  • Prat A; Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain.
  • Mellado B; Medical Oncology Service, Instituto Valenciano de Oncología (IVO), 46009 Valencia, Spain.
Cancers (Basel) ; 14(19)2022 Sep 29.
Article in En | MEDLINE | ID: mdl-36230681
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Type: Article Affiliation country: Spain